Both in Pharmaceuticals
XBiotech vs Verrica Pharmaceuticals
Over the past year XBIT returned −24.9% and VRCA returned −8.3%; their daily moves had a correlation of 0.02.
XBIT −24.9% VRCA −8.3%Growth of $1, one year, split-adjusted
| Metric | XBIT | VRCA |
|---|---|---|
| Price | $1.93 | $3.53 |
| Market cap | $58.8M | $60.6M |
| Today | −2.03% | −7.83% |
| 1 month | −10.6% | −19.0% |
| 6 months | −23.1% | −49.4% |
| Year to date | −19.2% | −57.5% |
| 1 year | −22.5% | −9.7% |
| Revenue growth (YoY) | — | −53.8% |
| Gross margin | — | 85.0% |
| Net margin | — | −224.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $109.5M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 29.5% | 63.2% |
| Short % of float | 2.0% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).